UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037754
Receipt number R000043057
Scientific Title Efficacy of insole on the treatment of neurological diseases
Date of disclosure of the study information 2019/08/21
Last modified on 2021/09/01 10:34:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of insole on the treatment of neurological diseases

Acronym

Efficacy of insole on the treatment of neurological diseases

Scientific Title

Efficacy of insole on the treatment of neurological diseases

Scientific Title:Acronym

Efficacy of insole on the treatment of neurological diseases

Region

Japan


Condition

Condition

parkinson disease, Parkinsonism, brain infarction

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the efficacy of insole on the motor dysfunction of neurological diseases

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Various walking parameters (e.g. 3-dimentional motion analysis and questionnaire)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

The condition that the insole is not worn.
The condition that the insole is worn.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with Parkinson desease, Parkinsonism and brain infarction.
Subject who come under all the following (1) and (2).
(1) Subject who can walk by alone or using walking aid.
(2) Subject who understands the purpose of this study and various instructions on this study and can informed consent for participation.

Key exclusion criteria

Subject who come under to any of the following (1) to (3).
(1) Subject who can not understands the purpose of this study and various instructions on this study and can not informed consent for participation.
(2) If it is difficult to wear the HONDA Walking Assistive Device.
(3) Subject who are judged as inappropriate to be enrolled in this study by principal investigator or member of this study project.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Masaki
Middle name
Last name Hasegawa

Organization

Prefectural University of Hiroshima

Division name

Faculty of Health and Welfare

Zip code

723-0053

Address

1-1 Gakuen-cho, Mihara-shi, Hiroshima 723-0053, Japan

TEL

0848-60-1230

Email

m-hasegawa@pu-hiroshima.ac.jp


Public contact

Name of contact person

1st name Masaki
Middle name
Last name Hasegawa

Organization

Prefectural University of Hiroshima

Division name

Faculty of Health and Welfare

Zip code

723-0053

Address

Gakuen-cho, Mihara-shi, Hiroshima 723-0053, Japan

TEL

0848-60-1230

Homepage URL


Email

m-hasegawa@pu-hiroshima.ac.jp


Sponsor or person

Institute

Prefectural University of Hiroshima

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Prefectural University of Hiroshima

Address

1-1 Gakuencho, Mihara city Hiroshima

Tel

0848-60-1230

Email

m-hasegawa@pu-hiroshima.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 08 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Suspended

Date of protocol fixation

2019 Year 09 Month 10 Day

Date of IRB

2019 Year 10 Month 15 Day

Anticipated trial start date

2019 Year 10 Month 15 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 08 Month 21 Day

Last modified on

2021 Year 09 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043057


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name